Sai Life Sciences: Change In Management - Appointment of SMPs
Sai Life Sciences (SAILIFE) filed a disclosure titled "Change In Management - Appointment of SMPs". The company is valued at about ₹33,849 crore.
What happened
Sai Life Sciences (SAILIFE) filed a disclosure with the exchanges on 5 November 2026 at 11:05 PM titled "Change In Management - Appointment of SMPs".
From the filing: "Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors has approved the appointment of following persons as Senior Management Personnel (SMP) of the Company with effect from 05 th November 2026 : A."
Company snapshot
Sai Life Sciences is a mid-cap company in the Healthcare sector, with a market value of about ₹33,849 crore.
The stock last traded at ₹1,594.5, against a 52-week range of ₹783.9–₹1,697 (6.0% below the high).
Before this filing the shares had moved +1.1% over the month and +14.0% over three months. Average daily turnover over the last 20 sessions was about ₹71.58 crore.
Promoters held 34.53% at the end of Q1 FY27, down 0.08% points from the previous quarter. Foreign institutions owned 19.65% and domestic institutions 32.71%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 496 | 60.5 | 2.9 |
| Q2 FY26 | 537 | 83.8 | 4.01 |
| Q3 FY26 | 556 | 100.4 | 4.77 |
| Q4 FY26 | 602 | 104.2 | 4.93 |
| Q1 FY27 | 554 | 73.3 | 3.46 |
What history shows
BCEIE's records show 1 previous management change filing from the company since May 2026.
Across 123 similar disclosures by other Healthcare companies, shares moved +1.1% on average the next day and +1.8% over five days; 50% of them rose the next day.
Market-wide, 4,295 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 45% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 5 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside
- JK Agri Genetics sells leasehold rights to Sai Life Sciences for ₹19.80 crore
- Sai Life Sciences Limited IPO GMP Today, Expected Listing Gain & Price Band
- Sai Life Sciences Ltd (NSE:SAILIFE) Q2 2027 Earnings Report Prev
- Sai Life Sciences - Concurrent Gainers: 8 stocks that gain for 5 days in a row
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.